Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Nurmohamed

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 19, 2021
Working towards full eradication of lipid-driven cardiovascular risk?N S Nurmohamed, E S G Stroes
Expert Review of Cardiovascular Therapy|June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemiaN S Nurmohamed, G M Dallinga-Thie, E S G Stroes
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 12, 2021
From evidence to practice: development of web-based Dutch lipid reference valuesN S Nurmohamed, D Collard, J W Balder, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 19, 2021
Working towards full eradication of lipid-driven cardiovascular risk?N S Nurmohamed, E S G Stroes
Expert Review of Cardiovascular Therapy|June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemiaN S Nurmohamed, G M Dallinga-Thie, E S G Stroes
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 12, 2021
From evidence to practice: development of web-based Dutch lipid reference valuesN S Nurmohamed, D Collard, J W Balder, et al.
Pageof 1